Indication
Candonilimab
1 clinical trial
1 product
1 drug
Clinical trial
Two Stage, Multi-center Trial of Candonilimab in Combination With LM-302 for Treatment of Patients With Claudin 18.2 Positive-advanced Biliary Tract Cancer After Failure of Standard of Chemotherapy and PD1/PD-L1 AntibodyStatus: Recruiting, Estimated PCD: 2025-08-01
Product
cardonilizumabDrug
LM-302